VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
-2.51%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$165M
AUM Growth
+$165M
(-58%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-119.61%
Top 10 Holdings %
Top 10 Hldgs %
89.08%
Holding
21
New
3
Increased
–
Reduced
13
Closed
–
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$1.96M |
| 2 |
PDS Biotechnology
PDSB
|
$1.69M |
| 3 |
CytomX Therapeutics
CTMX
|
$1.57M |
Top Sells
| 1 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$117M |
| 2 |
Regenxbio
RGNX
|
$17.1M |
| 3 |
Ascendis Pharma
ASND
|
$13.2M |
| 4 |
Arcturus Therapeutics
ARCT
|
$6.38M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$5.95M |
Sector Composition
| 1 | Healthcare | 68.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Heron Therapeutics
HRTX
$207M
| $29.3M | 17.68% | 1,095,734 | – | – |
|
|
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $21.7M | 13.09% | 311,853 | – | – |
|
|
ANAC
3
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $15.9M | 9.61% | 140,756 -1,037,718 | -88% | -$117M |
|
|
4
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $14M | 8.48% | 611,010 -259,259 | -30% | -$5.95M |
|
5
Lipocine
LPCN
$15.8M
| $11M | 6.64% | 849,921 -420,000 | -33% | -$5.43M |
|
6
Adverum Biotechnologies
ADVM
$64.6M
| $10.5M | 6.35% | 1,102,735 -280,000 | -20% | -$2.67M |
|
|
AVDL
7
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.11M | 3.69% | 500,000 | – | – |
|
8
Larimar Therapeutics
LRMR
$310M
| $3.41M | 2.06% | 541,480 | – | – |
|
|
9
Arcturus Therapeutics
ARCT
$462M
| $3.04M | 1.84% | 484,500 -1,015,500 | -68% | -$6.38M |
|
|
AKTX
10
Akari Therapeutics
AKTX
$24.8M
| $2.3M | 1.39% | 158,352 -369,490 | -70% | -$5.36M |
|
|
OCRX
11
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.2M | 1.33% | 703,730 | – | – |
|
|
ORKA
12
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
| $2.15M | 1.3% | 462,399 -1,078,932 | -70% | -$5.02M |
|
|
GBT
13
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.96M | 1.19% | +60,691 | New | +$1.96M |
|
|
14
PDS Biotechnology
PDSB
$57.8M
| $1.69M | 1.02% | +135,000 | New | +$1.69M |
|
|
15
Ascendis Pharma
ASND
$11.8B
| $1.65M | 1% | 90,000 -721,152 | -89% | -$13.2M |
|
|
16
CytomX Therapeutics
CTMX
$336M
| $1.57M | 0.95% | +75,000 | New | +$1.57M |
|
|
SRRA
17
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.13M | 0.68% | 75,000 -175,000 | -70% | -$2.63M |
|
|
18
Regenxbio
RGNX
$451M
| $872K | 0.53% | 52,500 -1,030,954 | -95% | -$17.1M |
|
|
STML
19
DELISTED
Stemline Therapeutics, Inc.
STML
| $855K | 0.52% | 135,420 -315,980 | -70% | -$2M |
|